Loading clinical trials...
Loading clinical trials...
The use of a novel topical mucosa composition (XCM-OM118) comprising 2-(trimethylazaniumyl) acetate; (2R,3R,4S)-pentane-1,2,3,4,5-pentol; Hexadecanoic acid; (9Z, 12Z)-octadeca-9,12-dienoic acid; octad...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Mucosa Innovations, S.L.
Collaborators
NCT05883540 · Palliative Care, Pain, and more
NCT07546435 · Psychological Experience in Fertility Treatment, Hypogonadism, and more
NCT06395558 · Cognitive Impairment, Depression, Anxiety, and more
NCT07282483 · Radiation-induced Oral Mucositis
NCT07339774 · Radiotherapy-induced Oral Mucositis
Mucosa Innovations S.L.
Madrid, Madrid
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions